Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 30 mL Multiple-Dose Vial

Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 30 mL Multiple-Dose Vial

Dexamethasone Sodium Phosphate Injection, USP (Product #67457042130 / NDC 67457-421-30) manufactured by Mylan Institutional LLC (a Viatris company) is a sterile, clear, colorless parenteral glucocorticoid solution intended for intravenous, intramuscular, intra-articular, intralesional, or soft tissue injection. Each milliliter contains dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate (or 3.33 mg dexamethasone equivalent). Formulated with benzyl alcohol (10 mg/mL) as a preservative, this versatile synthetic corticosteroid is supplied in a single 30 mL multiple-dose vial (120 mg total active dexamethasone phosphate per vial).

Add to Order Guide
Add to Order Guide

SKU: MYL 67457042312

Product Specifications

Specification Details
Manufacturer / Brand Mylan Institutional LLC / Viatris
Manufacturer SKU / Item # 67457042130
NDC Number 67457-421-30 (Vial)
Active Ingredient Dexamethasone Sodium Phosphate (4 mg/mL equivalent)
Concentration / Strength 4 mg/mL
Total Content per Vial 120 mg Dexamethasone Phosphate / 30 mL
Volume per Unit 30 mL
Container Type Glass Multiple-Dose Vial (MDV)
Administration Route Intravenous (IV), Intramuscular (IM), Intra-Articular, Intralesional, Soft Tissue
Formulation Preservative-Containing (10 mg/mL Benzyl Alcohol) / Sterile
Storage Temperature 20°C to 25°C (68°F to 77°F) (Protect from light and freezing)
Packaging Configuration 1 Vial per Box / Package
Regulatory Category Prescription-Only (Rx) / ANDA Approved
HCPCS Code

Key Features & Clinical Applications

  • Standard Anti-Inflammatory & Immunosuppressive Therapy: Provides rapid corticosteroid action across severe inflammatory conditions, acute allergic reactions, endocrine disorders, cerebral edema, and rheumatologic conditions.

  • Oncology & Surgical Adjunct: Widely utilized in hospital and outpatient oncology settings for the management of chemotherapy-induced nausea and vomiting (CNAV) and management of severe airway edema.

  • Versatile Multi-Route Administration: Suitable for systemic IV infusion/injection, deep IM administration, or targeted local injections (intra-articular, intralesional, or soft tissue).

  • High-Capacity 30 mL Multi-Dose Vial: The 30 mL (120 mg) format is ideal for high-volume hospital pharmacies, surgical suites, and outpatient clinics requiring flexible dose preparation.

⚠️ Preservative Hazard (Benzyl Alcohol Warning): Contains benzyl alcohol as a preservative. Benzyl alcohol is associated with serious adverse events, including “gasping syndrome” and death in neonates and low-birth-weight infants. Do not use in neonates, infants, or premature infants.

⚠️ Infection Masking & Immunosuppression: Corticosteroids may mask some signs of infection, and new infections may appear during their use. Avoid abrupt cessation following long-term therapy to prevent acute adrenal insufficiency.

⚠️ Route Precaution: Local administration (intra-articular) must be performed under strict aseptic conditions to prevent septic arthritis. Do not inject into unstable joints.

Unit of Measure

30mL Vial (EA/1)

Scroll to Top